1. El-Sherif N, Chinushi M, Caref EB, Restivo M. Electrophysiological mechanism of the characteristic electrocardiographic morphology of torsade de pointes tachyarrhythmias in the long-QT syndrome: detailed analysis of ventricular tridimensional activation patterns. Circulation. 1997; 96:4392–4399.
2. Tester DJ, Will ML, Haglund CM, Ackerman MJ. Effect of clinical phenotype on yield of long QT syndrome genetic testing. J Am Coll Cardiol. 2006; 47:764–768.
3. Angelini P. Coronary artery anomalies--current clinical issues: definitions, classification, incidence, clinical relevance, and treatment guidelines. Tex Heart Inst J. 2002; 29:271–278.
4. Shimizu W, Antzelevitch C. Sodium channel block with mexiletine is effective in reducing dispersion of repolarization and preventing torsade des pointes in LQT2 and LQT3 models of the long-QT syndrome. Circulation. 1997; 96:2038–2047.
5. Kawabata M, Hirao K, Takeshi S, et al. Torsades de pointes related to transient marked QT prolongation following successful emergent percutaneous coronary intervention for acute coronary syndrome. J Electrocardiol. 2008; 41:117–122.
6. Moreno FL, Villanueva T, Karagounis LA, Anderson JL. TEAM-2 Study Investigators. Reduction in QT interval dispersion by successful thrombolytic therapy in acute myocardial infarction. Circulation. 1994; 90:94–100.
7. Chauhan VS, Tang AS. Dynamic changes of QT interval and QT dispersion in non-Q-wave and Q-wave myocardial infarction. J Electrocardiol. 2001; 34:109–117.